No,in the open label study there was a nine fold i

No,in the open label study there was a nine fold improvement in mortality. Of 319 drugs in current studies RLF-100 is amongst the twenty chosen for EAP and one of the very few chosen for the ISPY protocol through Quantum. They changed primary endpoint to make EUA much more simple. Just responding to your query, delete based on your judgment.